AI Verdict
HROW has stronger fundamentals based on our AI analysis.
HROW vs HRGN Fundamental Comparison
| Metric | HROW | HRGN |
|---|---|---|
| Revenue | $272.3M | $704,000.0 |
| Net Income | $-5.1M | $-6.9M |
| Net Margin | -1.9% | -975.7% |
| ROE | -9.8% | -649.9% |
| ROA | -1.3% | -256.6% |
| Current Ratio | 2.20x | 1.19x |
| Debt/Equity | 4.77x | 0.00x |
| EPS | $-0.14 | $-0.44 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HROW vs HRGN: Frequently Asked Questions
Is HROW or HRGN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HROW has stronger fundamentals. HROW is rated HOLD (68% confidence) while HRGN is rated STRONG SELL (85% confidence). This is not investment advice.
How does HROW compare to HRGN fundamentally?
HARROW, INC. has ROE of -9.8% vs Harvard Apparatus Regenerative Technology, Inc.'s -649.9%. Net margins are -1.9% vs -975.7% respectively.
Which stock pays higher dividends, HROW or HRGN?
HROW has a dividend yield of N/A or no dividend while HRGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HROW or HRGN for long term?
For long-term investing, consider that HROW has HOLD rating with 68% confidence, while HRGN has STRONG SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HROW vs HRGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HROW vs HRGN, the AI consensus favors HROW based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.